
Sunday, February 04, 2024 10:40:36 AM
- Calculated current number of XOS shares based on initial merger PR stating that XOS management owns 3.23 million shares, representing 49.5% of all outstanding XOS shares, so XOS outstanding shares = 3.23/0.495 = 6.5 million.
- After the merger XOS will own 79% of the shares in the combined company, which can be estimated by 6.5/0.79 = 8, or 8 million shares.
- SOLO shares = 8 - 6.5 = 1.5 million
- There are currently 119 outstanding SOLO shares, so exchange ratio = 1.5/119 = 0.01261
- Assuming a combined company worth of $100 million, XOS shares would be worth 100/8=12, or $12 a share at time of merger, SOLO shares at time of merger would be worth 0.21x$100=$21 million/119 million oustanding shares = $0.18
The share information in the initial merger announcement PR, was given only to show the likelihood of the merger being approved. A 2/3 majority of votes from both shareholders is needed. XOS management, owning 50% of outstanding shares, pretty much guarantees approval. However, SOLO management only owns 2-3% of outstanding shares, so not a guarantee. Since only voted shares count, it should increase the likelihood that the merger is approved by shareholders of both companies.
4Cable TV International, Inc. To Change Name to Opus Holdings, Inc. Set to Launch New Business Model with Potential Shareholder Dividends and a Fresh Leadership Team • CATV • Mar 25, 2025 8:30 AM
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company's Vision AI Platform • AVAI • Mar 25, 2025 8:00 AM
HealthLynked Announces Enhanced Patient In-Office Booking and Upgrades to ARi Healthcare Assistant • HLYK • Mar 24, 2025 8:00 AM
LaFleur Minerals Provides Update on Beacon Mill Restart, Results of Annual General and Special Meeting, and Swanson Gold Deposit Exploration and Drilling Updates • LFLRF • Mar 21, 2025 9:40 AM
Basanite Industries, Inc. Appoints Michael D. Nelson as Chief Executive Officer • BASA • Mar 21, 2025 9:01 AM
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation • FITY • Mar 20, 2025 9:00 AM